LeMaitre Vascular, Inc. (LMAT) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $117.39. It has a SharesGrow Score of 73/100, indicating a above average investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LMAT = $103.28 (-12% from the current price, the stock appears overvalued). Analyst consensus target is LMAT = $102 (-13.5% upside).
Valuation: LMAT trades at a trailing Price-to-Earnings (P/E) of 43.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 4.56.
Financials: revenue is $250M, +15.6%/yr average growth. Net income is $58M, growing at +41.1%/yr. Net profit margin is 23.1% (strong). Gross margin is 71.5% (+6.6 pp trend).
Balance sheet: total debt is $186M against $394M equity (Debt-to-Equity (D/E) ratio 0.47, conservative). Current ratio is 12.89 (strong liquidity). Debt-to-assets is 30.1%. Total assets: $616M.
Analyst outlook: 14 / 20 analysts rate LMAT as buy (70%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 14/100 (Fail), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 70/100 (Pass), Future 49/100 (Partial), Income 85/100 (Pass).
